02186.HK
Luye Pharma Group Ltd.
HKSE · Healthcare · Drug Manufacturers - General · CN
HKD 1.90
+1.07%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
2.0x
Market Cap
HKD 7.66B
MomentumView details →
1D Return
+1.07%
YTD Return
−30.84%
RSI (14)
38.4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
2.0x
Market Cap
HKD 7.66B
RSI (14)
38.4
MomentumView details →
1D Return
+1.07%
YTD Return
−30.84%
Similar companies
Latest newsMore news →
Shandong Commercial Group transferred 5% of Furuida's shares to Shandong State-owned Assets Investment Holding Co., Ltd., completing registration on August 31, 2026.3d agoLuye Pharma Group announced its interim results for the six months ended June 2026, with net profit of RMB 390 million, up 24.8% year-on-year, and revenue of RMB 3.002 billion, down 5.6%.5d ago